REG-Nyxoah Announces Preliminary Results for the Second Quarter of 2026
Nyxoah reported preliminary Q2 2026 global net revenue of €7.7 million, representing 21% sequential growth driven by continued momentum in the U.S. market. The company secured $110 million in aggregate financing during the quarter, bringing cash, cash equivalents, and financial assets to approximately €97.8 million as of June 30, 2026.
Key figures
- Revenue
- €7.7 million
- Guidance
- €36 million to €40 million
- Us revenue
- €5.2 million
- Cash balance
- €97.8 million
- Cms asc increase
- 15%
- Financing secured
- $110 million
- Cms hospital increase
- 12%
- Us revenue seq growth
- 22%
- Global revenue seq growth
- 21%
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.